UPDATE: Valeant Pharma (VRX) Says Aware of T. Rowe Price Filing and Hasn't Been Served Yet

August 18, 2016 3:40 PM EDT

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
(Updated - August 18, 2016 3:41 PM EDT)

Valeant Pharma (NYSE: VRX) announced the following on Thursday:

We are aware of the filing and have not been served yet. This T. Rowe Price complaint repeats allegations and claims as in the pending securities putative class action brought against Valeant by TIAA-CREF. As with the original complaint, which was filed in October 2015, Valeant intends to defend itself and cannot comment further on ongoing litigation.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, Litigation

Add Your Comment